Clinical Trials Logo
  1. Home
  2. Medical Abortion
  3. NCT01856777

Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy

Medical Abortion Clinical Trial

Official title:
Evaluating the Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy After Early Medical Abortion

Clinical Trial Summary

This randomized study will examine the effectiveness of two types of pregnancy tests (a semi-quantitative test and a high sensitivity test) to identify continuing pregnancy at home at various time points after early medical abortion. The first test a semi-quantitative panel test marketed under the brand name dBest (AmeriTek, Seattle WA, USA). This urine-based, one-step kit has been used in two previous studies in Vietnam (12, 13). The second test is a locally available urine dipstick (Quickstick one-step hCG Pregnancy Test, Phamatech, San Diego, CA, USA).

1. The investigators hypothesize that 99% of the SQPT and 35% of the HSPT will correctly identify ongoing pregnancy at day 14.

2. The investigators hypothesize that 99% of the SQPT and 25% of the HSPT will correctly identify ongoing pregnancy at day 7.

3. The investigators hypothesize that 75% of the SQPT and 10% of the HSPT will correctly identify ongoing pregnancy at day 4.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01856777
Study type Interventional
Source Gynuity Health Projects
Contact
Status Completed
Phase N/A
Start date June 2013
Completion date February 2014
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02745093 - Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Phase 4
Completed NCT02570204 - Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests N/A
Completed NCT01487213 - Routine Follow-up Versus Self-assessment in Medical Abortion N/A
Terminated NCT05119439 - Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks Phase 4
Terminated NCT04941443 - Methadone and Medication Abortion Phase 4
Completed NCT02985229 - Acceptability and Feasibility of Medical Abortion in Singapore Phase 3
Completed NCT01920022 - Quickstart of Nexplanon® at Medical Abortion Phase 4
Completed NCT00472394 - Determining Women's Preferences for Medical Abortion Using Willingness to Pay N/A
Completed NCT03604341 - Cannabinoids for Pain Control During Medical Abortion Phase 4
Completed NCT00907725 - Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion? N/A
Completed NCT00120224 - De-Medicalizing Mifepristone Medical Abortion N/A
Completed NCT03148587 - Medical Abortion Self-Confirmation (MASC) N/A
Completed NCT00621543 - Insertion of an Intrauterine Device (IUD) After Medical Abortion N/A
Completed NCT02343913 - Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan N/A
Recruiting NCT00920465 - Treatment Regimens for Mifegyne and Cytotec Phase 3
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Completed NCT00997347 - The Extended Gestational Age Medical Abortion Study Phase 4
Completed NCT03014193 - Simplifying First Trimester Medical Abortion Follow-up N/A
Recruiting NCT04905251 - Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A